Latest news with #MichaelJFoster
Business Insider
13-07-2025
- Business
- Business Insider
Wells Fargo Sticks to Its Buy Rating for Sabra Healthcare REIT (SBRA)
Wells Fargo analyst maintained a Buy rating on Sabra Healthcare REIT on July 11 and set a price target of $20.00. The company's shares closed last Friday at $18.46. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Currently, the analyst consensus on Sabra Healthcare REIT is a Moderate Buy with an average price target of $19.40, which is a 5.09% upside from current levels. In a report released on July 8, Bank of America Securities also reiterated a Buy rating on the stock with a $20.00 price target. The company has a one-year high of $20.03 and a one-year low of $15.60. Currently, Sabra Healthcare REIT has an average volume of 2.55M. Based on the recent corporate insider activity of 68 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of SBRA in relation to earlier this year. Most recently, in May 2025, Michael J Foster, a Director at SBRA sold 11,000.00 shares for a total of $200,310.00.
Business Insider
12-07-2025
- Business
- Business Insider
Sabra Healthcare REIT (SBRA) Receives a Buy from Bank of America Securities
In a report released on July 8, Jeffrey Spector from Bank of America Securities reiterated a Buy rating on Sabra Healthcare REIT, with a price target of $20.00. The company's shares closed yesterday at $18.46. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Spector covers the Real Estate sector, focusing on stocks such as Agree Realty, Cousins Properties, and Welltower. According to TipRanks, Spector has an average return of 3.2% and a 46.63% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Sabra Healthcare REIT with a $19.67 average price target. The company has a one-year high of $20.03 and a one-year low of $15.60. Currently, Sabra Healthcare REIT has an average volume of 2.55M. Based on the recent corporate insider activity of 68 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of SBRA in relation to earlier this year. Most recently, in May 2025, Michael J Foster, a Director at SBRA sold 11,000.00 shares for a total of $200,310.00.
